George Church (geneticist)

Early life and education

Church was born on August 28, 1954, on MacDill Air Force Base in Tampa, Florida, and grew up in nearby Clearwater, Florida. He attended high school at the preparatory boarding school Phillips Academy, in Andover, Massachusetts, from 1968 to 1972. He then attended Duke University, where he obtained a B.S. degree in zoology and chemistry in two years.

In the fall of 1973, Church began research work at Duke University with assistant professor of biochemistry Sung-Hou Kim, work that continued a year later in a graduate biochemistry program at Duke on an National Science Foundation fellowship.

As Peter Miller reported on Church for the National Geographic series, "The Innovators": As a result, Church was not compliant with Duke graduate academic policies, and was withdrawn from the degree program in January 1976. He was told that "[We] hope that whatever problems ... contributed to your lack of success ... at Duke will not keep you from a successful pursuit of a productive career." The work gave rise to publications including a PNAS report with Church as lead author on an early model for molecular interactions between the minor groove of double-stranded DNA and β-ribbons of proteins.

Church returned to graduate work at Harvard University in 1977 under Walter Gilbert, and completed a Ph.D in biochemistry and molecular biology working on mobile genetic elements within introns of yeast mitochondrial and mouse immunoglobulin genes (1984).

Career

After completing his doctoral work, Church spent six months of 1984 at Biogen, the industrial laboratory site where Gilbert had relocated a sizable part of his former Harvard group.{{Cite journal

Church joined the Harvard Medical School faculty as an assistant professor in 1986. and a member of the Harvard-MIT health sciences and technology faculty. He was also a founding member of the Wyss Institute for Biologically Inspired Engineering at Harvard University.

He co-founded Veritas Genetics and its European and Latin American subsidiary, Veritas Intercontinental, with the idea of bringing the benefits of genomic data to millions of people globally.

Church was elected a member of the National Academy of Engineering in 2012 for contributions to human genome sequencing technologies and DNA synthesis and assembly.

In 2018, Church co-founded Nebula Genomics, a personal genomics company that offers a whole-genome sequencing service. The company says that it is developing its own blockchain, intending to provide free sequencing in exchange for users' genomic and personal data. The decentralized nature of a blockchain also has the potential to improve aspects of data privacy and security, but identification of individuals could still be possible (DNA itself is a unique identifier) and law enforcement could still issue search warrants or subpoena the data.

In 2021, Church joined as a co-founder of HLTH.network (formerly Shivom), a healthcare blockchain startup which created the world's first global genomics data sharing and analytics marketplace. The HLTH.network aims to be the "world's first base layer protocol for global health data." In 2025, Church joined Lila Sciences, an AI agent platform startup, as Chief Scientist.

George Church Institute of Regenesis: collaboration with BGI Group, China

Since 2007, Church has served on the scientific advisory board of BGI Group.

In 2017, BGI established the "George Church Institute of Regenesis", a research collaboration between Church's lab and about a dozen staffers at BGI in China. Dr. Xun Xu, executive director of BGI Group said:

On February 18, 2020, Nebula Genomics, a personal genomics company founded by Church, announced that had partnered up with BGI; the saliva samples sent to Nebula Genomics for decoding are then sent by the company to BGI labs in Hong Kong for sequencing. Nebula Genomics said that this partnership was made to bring down the cost of whole-genome sequencing (they offer 30x whole-genome sequencing for $299), since normally it has a cost that makes it inaccessible to most people.

Research

Church is known for his professional contributions in the sequencing of genomes and interpreting such data, in synthetic biology and genome engineering, and in an emerging area of neuroscience that proposes to map brain activity and establish a "functional connectome". Church is known for pioneering the specialized fields of personal genomics and synthetic biology. He has co-founded commercial concerns spanning these areas, and others from green and natural products chemistry to infectious agent testing and fuel production, including Knome, LS9, and Joule Unlimited (respectively, human genomics, green chemistry, and solar fuel companies).

Church and the foundation of genomics

With Walter Gilbert, Church published the first direct genomic sequencing method in 1984. Described in that publication were the cyclic application of fluids to a solid phase alternating with imaging, plus avoidance of bacterial cloning, strategies that are still used in current dominant Next-Generation Sequencing technologies. These technologies began to affect genome-scale sequencing in 2005. Church also helped initiate the Human Genome Project in 1984. He invented the broadly applied concepts of molecular multiplexing and barcode tags, and his genome was the fifth whole human genome ever sequenced. Church was the first person to make his medical records and genome publicly available to researchers. Technology transfer of automated sequencing and software from his Harvard laboratory to Genome Therapeutics Corp. resulted in the first bacterial genome sequence and first commercial genome (the human pathogen Helicobacter pylori) in 1994. Church was co-inventor of nanopore sequencing in 1995, which is now commercially available (e.g. Oxford Nanopore Technologies), but not in the form embodied in Church's contribution to the original patents.

To aid in the interpretation and sharing of genomes, Church initiated the Personal Genome Project (PGP) in 2005, providing the world's only open-access human genome and trait data sets.

Church furthermore announced his intention to publish his DNA via NFT and use the profits made through its sale to finance research conducted by Nebula Genomics. In June 2022 20 NFTs with his likeness were published instead of the originally planned NFTs of his DNA due to the market conditions at the time. Despite leading to mixed reactions the project is considered to be part of an effort to use the genetic data of 15,000 individuals to support genetic research. By using NFTs the project wants to ensure that the users submitting their genetic data are able to receive direct payment for their contributions.

Synthetic biology and genome engineering

Church has co-developed "genome engineering" technologies since 1997 via either general homologous recombination (recA and lambda-red) or via sequence-specific nucleases. He co-developed Multiplex Automated Genome Engineering (MAGE) and optimized CRISPR/Cas9, discovered by Jennifer Doudna and Emmanuelle Charpentier for engineering a variety of genomes ranging from yeast to human. His laboratory's use of CRISPR in human induced pluripotent stem cells (hiPS) is the latest contender for precise gene therapy.

His team is the first to tackle a genome-scale change in the genetic code. This was done in a 4.7 million basepair genome of an industrially useful microbe (E. coli) with the goal of making a safer and more productive strain; this strain uses non-proteinogenic amino acids in proteins, and is metabolically and genetically isolated from other species.

He has co-invented several uses for DNA, including detectors for dark matter – Weakly interacting massive particles (WIMPs), anti-cancer "nano-robots", and strategies for digital data storage that are over a million times denser than conventional disk drives. Together with polymerase, DNA can be used to sense and store variation in photons, nucleotides, or ions.

The BRAIN initiative

Church was part of a team who, in a 2012 scientific commentary, proposed a Brain Activity Map, later named BRAIN Initiative (Brain Research through Advancing Innovative Neurotechnologies). They outlined specific experimental techniques that might be used to achieve what they termed a "functional connectome", as well as new technologies that will have to be developed in the course of the project, including wireless, minimally invasive methods to detect and manipulate neuronal activity, either utilizing microelectronics or synthetic biology. In one such proposed method, enzymatically produced DNA would serve as a "ticker tape record" of neuronal activity.

Gene therapy, ageing, and age reversal

Church worked on engineered adeno-associated viral vectors to evade innate immune and inflammatory responses. The research was published in Science Translational Medicine in 2021 and showed the possibility of a less immunogenic gene therapy with the new TLR9-edited Adeno-associated viruses (AAV) as a safer viral vector. Based on the research, Church and a postdoc from his lab who was also the first-author of the research, co-founded Ally Therapeutics. In 2017, the Church lab at Harvard created adeno-associated virus (AAV)-based single combination gene therapy "for simultaneous treatment of several age-related diseases", detailing the technology's efficacy in mitigating obesity, type II diabetes, heart failure, and renal failure in mice, and the work was published in PNAS. In early 2018, Rejuvenate Bio was launched from the Church lab at the Wyss Institute at Harvard to prevent and treat several age-related diseases in dogs, extending their overall lifespan. In the February 2020, Rejuvenate Bio, the company co-founded by Church, received an exclusive worldwide license from the Harvard Office of Technology Development to commercialise their gene therapy technology. As the co-founder of Rejuvenate Bio in an interview Church said: The research group's progress toward gene therapy for aging has been very limited, however. A 2022 PNAS paper from the Church group has already been the subject of two corrections, one for incomplete conflict of interest disclosures and one for image duplication.

Space biology and space genetics

Church is a faculty member in the Consortium of Space Genetics at Harvard Medical School.

De-extinction, woolly mammoth revival project, and Colossal Biosciences

In March 2015, Church and his genetics research team at Harvard successfully copied some woolly mammoth genes into the genome of an Asian elephant. Using the CRISPR DNA editing technique, his group spliced genetic segments from frozen mammoth specimens, including genes from the ears, subcutaneous fat, and hair attributes, into the DNA of skin cells from a modern elephant. National Geographic, in an article titled "Mammoth-elephant hybrids could be created within the decade. Should they be?", reported:

This marked the first time that woolly mammoth genes had been functionally active since the species became extinct. Their work has not been subject to peer review, however. Church stated that "Just making a DNA change isn't that meaningful. We want to read out the phenotypes." To do that, the team plans to perform further tests to get the hybrid cells into becoming specialized tissues, and from there attempting to turn the hybrid elephant/mammoth skin cells into hybrid embryos that can be grown in artificial wombs.

On September 13, 2021, Church founded a biosciences and genetics company, Colossal Biosciences, with entrepreneur Ben Lamm. The company is attempting to use genetic code to revive the woolly mammoth by equipping Asian elephants with mammoth traits.

Laetitia Garriott de Cayeux, founder-CEO of Global Space Ventures and an investor in Colossal Biosciences, said: In 2013, in response to a question from Der Spiegel, Church speculated that it could be technically possible to make a Neanderthal by reconstructing its DNA and modifying living human cells accordingly. Translation issues and misreporting led some media outlets to believe that Church was working on such a project and searching for a surrogate mother, causing controversy. Church clarified that he was not.

In 2025, Colossal reported the live birth of two "dire wolves" where gray wolf cells received 20 unique gene edits, including 15 edits that directly matched dire wolf DNA and notably an edit that re-introduced pale coat color.

Technology transfer, translational impact, and serial entrepreneurship

Through his Harvard lab, Church has co-founded around 50 biotech companies, including Veritas Genetics (human genomics, 2014, with Mirza Cifric, Preston Estep, Yining Zhao, Joe Thakuria), Warp Drive Bio (natural products, 2011, with Greg Verdine and James Wells), Alacris (cancer systems therapeutics, 2010, with Hans Lehrach, Bernhard Herrmann, and Shahid Imran), Knome (human genomics, 2007, with Jorge Conde and Sundar Subramaniam), Pathogenica (microbe and viral NGS diagnostics, 2009, with Yemi Adesokan), AbVitro (immunomes, 2010, with Francois Vigneault), Gen9 Bio (synthetic biology, 2009, with Joseph Jacobson and Drew Endy), EnEvolv (Genome Engineering), Joule Unlimited (SolarFuels, 2007, with Noubar Afeyan and David Berry), LS9 (green chemistry, 2005, with Chris Somerville, Jay Keasling, Vinod Khosla, Noubar Afeyan, and David Berry), and ReadCoor (spatial biology, 2016, with Richard Terry and Evan R. Daugharthy).

Support of open consent

Church spearheaded the concept and implementation of open access sequencing hardware and shareable human medical data. He has noted the potential for re-identification of human research participants and the tendency for consent forms to be opaque – proposing an alternative "open consent" mechanism. cautioning about the risk of synthetic DNA and proposing risk-reduction via licensing and surveillance. His laboratory has a major bio-safety engineering focus.

Church's detailed online register of funding sources showed that he received funding from the nonprofit Jeffrey Epstein VI Foundation from 2005 to 2007. Church said in 2019 that he regrets he didn't know more about the donor.

Support of open education

Church is an advisor to the Personal Genetics Education Project and has spent a day teaching at The Jemicy School. He has promoted citizen science, especially in the fields of synthetic biology and personal genomics. Since 2008, his team has been hosting an annual Genomes, Environments and Traits (GET) Conference with free online videos.

Rapid Deployment Vaccine Collaborative

Church is a member of the Rapid Deployment Vaccine Collaborative (RaDVaC), a group formed early in the SARS-CoV-2 pandemic to create an easily produced, free and open-source vaccine for self-administration.

Popular science

In his science and popular efforts, Church has promoted open access genome sequencing and shareable human medical data, as well as online, open education and citizen science.

Church authored the 2012 New Scientist's "top science book", Regenesis: How Synthetic Biology Will Reinvent Nature and Ourselves with Ed Regis. He has participated in news interviews and videos including at TED, TEDx, and TEDMED venues, at PBS's Charlie Rose, Faces of America, and NOVA, as well as at PopSci, EG, and The Colbert Report. He is a regular contributor to Edge.org publications and videos and is a member of the Xconomists, an ad hoc team of editorial advisors for the tech news and media company, Xconomy.

In 2015, Jeneen Interlandi wrote an article on Church for Popular Science titled "The Church Of George Church: From reviving extinct species to hunting for dark matter, can a single scientist transform biology—and our lives?", where she states:

Awards and honors

Church has received accolades including election to the National Academy of Sciences (in 2011), and the National Academy of Engineering (in 2012). He received the American Society for Microbiology Promega Biotechnology Research Award and the Bower Award and Prize for Achievement in Science of the Franklin Institute. He authored the NewScientist "top science book", Regenesis (on synthetic biology) with Ed Regis.

Other honors include the Triennial International Steven Hoogendijk Award in 2010 and the Scientific American Top 50 twice (for "Designing artificial life" in 2005 and "The $1000 genome" in 2006). Newsweek picked Church for their 2008 "Power of Ideas" recognition in the category of Medicine (for the Personal Genome Project). In September 2010, Church was honored for his work in genetics with the Mass High Tech All-Star Award.

He is a member of the Research Advisory Board of SENS Research Foundation.

Personal life

Church is married to fellow Harvard Medical School faculty member in genetics Ting Wu.

Church has been outspoken in his support of following a vegan lifestyle, for reasons concerned with health, and with environmental and moral issues. When asked about his dietary choice, Church replied, "I've been vegan off-and-on since 1974 when I was inspired by participating in an MIT nutritional study, and quite strictly since 2004." He goes on to elaborate 4 reasons:

George identifies as a sentientist. Sentientism is a naturalistic worldview that grants moral consideration to all sentient beings.

In the context of the Personal Genome Project, journalists at Forbes and Wired have noted Church's openness about his health issues, including dyslexia, narcolepsy, and high cholesterol (one of the motivations for his vegan diet). Church has many of his best ideas during the brief naps caused by his narcolepsy, and therefore does not treat it.

Church collaborated with transhumanist entrepreneur James Clement on the Supercentenarian Research Study, which aims to sequence the genomes of supercentenarians in hopes of discovering potential genetic factors behind their longevity. As of 2023, he is part of the Enhanced Games scientific and ethical advisory commission.

Bibliography

• Regenesis (2014).
• Polony Sequencing (2007).

References

References

1. (August 2018). "Church, George". The H. W. Wilson Company}} {{dead link.
2. "Multiplex genome sequencing and analysis".
3. (October 7, 2020). "CRISPR, the revolutionary genetic 'scissors,' honored by Chemistry Nobel".
4. (February 4, 2014). "Bower Laureates". The Franklin Institute.
5. "Professor George M. Church".
6. "George Church: The World's 100 Most Influential People".
7. (2020-09-20). "The Future of Synthetic Biology with Prof. George Church".
8. {{GoogleScholar|id=SfDzdgEAAAAJ}}
9. {{Scopus
10. "Newcos GClab".
11. DeFrancesco, Laura. (2020-01-01). "One year, 1 lab, 16 spinouts". Nature Biotechnology.
12. (April 2022). "Thirty-Eight Special: George Church Pushes the Biotech Envelope". Gen Biotechnology.
13. (2021-08-11). "GC-Main".
14. (2022-07-20). "George M. Church, Ph.D.".
15. (April 26, 2017). "Harvard Geneticist George Church Gives Moving Toast At 2017 Time 100 Gala | Time 100 | Time".
16. "George Church Toasts the 2017 Time 100 Gala".
17. (May 9, 2022). "Most influential people in biopharma—the scientists".
18. (March 30, 2017). "Board of Sponsors".
19. Brock, David C.. (March 3, 2008). "George M. Church, Transcript of Interviews Conducted by David C. Brock in New Orleans, Louisiana on 3 March 2008". [[Chemical Heritage Foundation]].
20. David Ewing Duncan, 2010, [https://www.nytimes.com/2010/06/08/science/08church.html "On a Mission to Sequence the Genomes of 100,000 People: The geneticist George Church advises or licenses technology to most companies involved in sequencing"], ''[[The New York Times]]'', June 7, 2010. Retrieved February 26, 2015.
21. (April 17, 2009). "The Phillipian".
22. Peter Miller, 2015, "News, The Innovators Project: George Church, The Future Without Limits", ''National Geographic'' (online), see [https://web.archive.org/web/20140604093256/http://news.nationalgeographic.com/news/innovators/2014/06/140602-george-church-innovation-biology-science-genetics-de-extinction/]. Retrieved 26 February 2015.
23. Duke University Graduate School, Office of the Dean, 1976, [http://arep.med.harvard.edu/gmc/F.jpg "Dear Mr. Church ..."], January 16, 1976, private letter from W.G. Katzenmeyer, Associate Dean, to George McDonald Church, in the archives of G.M. Church. Retrieved March 4, 2015.
24. (1977). "Secondary structural complementarity between DNA and proteins.". Proceedings of the National Academy of Sciences.
25. link. (April 2, 2015. Retrieved March 21, 2014.)
26. Church, George. (1984). "Genetic Elements within Yeast Mitochondrial and Mouse Immunoglobulin Introns (Sequence, Enhancer, Technique)". Harvard University.
27. LSRF, 2015, "Resources, 1983 Fellow George Church", see [http://www.lsrf.org/resources/resources-detail-view/1983-fellow-george-church] {{Webarchive. link. (July 12, 2018. Retrieved February 26, 2015.)
28. LSRF, 2015, "Fellows:Alumni, George Church (1984)", see [http://www.lsrf.org/fellows/alumni]. Retrieved February 26, 2015.
29. Elie Dolgin, 2009, [http://www.the-scientist.com/?articles.view/articleNo/27244/title/Stem-cell-rat-race/ "Stem cell rat race"], ''[[The Scientist (magazine). The Scientist]]'', April 1, 2009. Retrieved February 26, 2015.
30. Martin G. (December 1981). "Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.". Proc Natl Acad Sci USA.
31. (August 5, 2016). "George Church, Ph.D.".
32. (February 18, 2020). "Nebula Genomics, Partnering with BGI, Sets Industry Standard by Offering 30x Whole-Genome Sequencing for $299".
33. Weintraub, Karen. (November 17, 2018). "Genetics Start-Up Wants to Sequence People's Genomes for Free".
34. Molteni, Megan. (September 19, 2019). "You Can Soon Get Your DNA Sequenced Anonymously".
35. Quinn, Kevin. (November 21, 2019). "Privacy Policy".
36. "Genomics Pioneer George Church Becomes Co-Founder of Shivom".
37. "HLTH – The Global Healthcare Ecosystem".
38. (2025-05-28). "Why George Church took chief scientist role at a Cambridge AI startup".
39. (2020-07-02). "California rejected Chinese company's push to help with coronavirus testing. Was that the right move?". The Washington Post.
40. "BGI Launches George Church Institute".
41. "Meet Prof. George Church | Nebula Genomics".
42. (July 2, 2020). "California rejected Chinese company's push to help with coronavirus testing. Was that the right move?". [[Washington Post]].
43. (February 18, 2020). "Nebula Genomics, Partnering with BGI, Sets Industry Standard by Offering 30x Whole-Genome Sequencing for $299".
44. (1984). "Genomic sequencing". Proceedings of the National Academy of Sciences of the United States of America.
45. (1986). "Genomic sequencing reveals a positive correlation between the kinetics of strand-specific DNA demethylation of the overlapping estradiol/glucocorticoid-receptor binding sites and the rate of avian vitellogenin mRNA synthesis". Proc. Natl. Acad. Sci. U.S.A..
46. (2005). "Accurate Multiplex Polony Sequencing of an Evolved Bacterial Genome". Science.
47. Cook-Deegan RM. (1989). "The Alta summit, December 1984". Genomics.
48. (1988). "Multiplex DNA sequencing". Science.
49. Srikanth, Anagha. (April 19, 2021). "First genomic NFT to be sold for science — and a statement".
50. (1996). "Capitalizing on the genome". Nature Genetics.
51. (November 25, 2016). "The Oxford Nanopore MinION: Delivery of nanopore sequencing to the genomics community". Genome Biology.
52. (October 3, 2012). "Genia Technologies Collaborates with Professors Jingyue Ju at Columbia and George Church at Harvard to Develop a Nanopore-based Sequencing Platform".
53. Church GM. (2005). "The Personal Genome Project". Molecular Systems Biology.
54. Ian L. Marpuri. (April 8, 2013). "Researchers explore genomic data privacy and risk (NIH NHGRI)".
55. "Okay, You've Sequenced My Genome: Are You Sure You Got it Right?". NGS Leaders.
56. (2021-06-18). "How scientists are embracing NFTs". Nature.
57. Tangermann, Victor. (2022-04-21). "A Harvard Scientist is Selling his Genetic Code as an NFT".
58. (1997). "Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: Application to open reading frame characterization". Journal of Bacteriology.
59. (2004). "Accurate Multiplex Gene Synthesis from Programmable DNA Chips". Nature.
60. (February 15, 2013). "RNA-guided human genome engineering via Cas9". Science.
61. Matthew Herper. (March 19, 2013). "This Protein Could Change Biotech Forever".
62. (2011). "Precise Manipulation of Chromosomes in vivo Enables Genome-wide Codon Replacement". Science.
63. (July 2, 2012). "Revolutionary 'DNA Tracking Chamber' Could Detect Dark Matter".
64. Belle Dumé. (February 17, 2012). "DNA nanorobot delivers drugs". Physics World.
65. Robert Lee Hotz. (August 16, 2012). "Future of Data: Encoded in DNA". The Wall Street Journal.
66. John Markoff. (February 17, 2013). "Obama Seeking to Boost Study of Human Brain". The New York Times.
67. (June 2012). "The Brain Activity Map Project and the Challenge of Functional Connectomics". [[Neuron (journal).
68. (2021). "Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses". Science Translational Medicine.
69. (February 10, 2021). "Biotech entrepreneur George Church launches gene therapy startup to design safer viral vectors". Fierce Biotech.
70. (February 12, 2021). "Biotech entrepreneur George Church launches gene therapy startup to design safer viral vectors".
71. (November 19, 2019). "A single combination gene therapy treats multiple age-related diseases". Proceedings of the National Academy of Sciences.
72. (October 5, 2021). "Rejuvenate Bio is Reversing Age-Related Diseases to Increase Healthspan".
73. "Rejuvenate Bio".
74. "Harvard's Wyss Institute launches start-up Rejuvenate Bio to help dogs live longer, healthier lives".
75. "Rejuvenate Bio launches to help dogs live longer, healthier lives".
76. (6 February 2020). "Rejuvenate Bio launches to help dogs live longer, healthier lives".
77. (2022-05-17). "New intranasal and injectable gene therapy for healthy life extension". Proceedings of the National Academy of Sciences.
78. "George M. Church, Ph.D. | Consortium for Space Genetics".
79. Sarah Fecht. (March 24, 2014). "Woolly Mammoth DNA Successfully Spliced into Elephant Cells". [[Popular Science]].
80. "Harvard Wyss Institute and Colossal Foundation Advance Artificial Womb Tech {{!}} EdTech News".
81. Michael Greshko. (September 13, 2021). "Mammoth-elephant hybrids could be created within the decade. Should they be?". National Geographic.
82. Zimmer, Carl. (September 13, 2021). "A New Company With a Wild Mission: Bring Back the Woolly Mammoth".
83. (August 6, 2021). "The Science of Genetics. The Business of Discovery".
84. (13 September 2021). "Global Space Ventures backs Colossal's seed round". Global Space Ventures.
85. (January 18, 2013). "How DNA will be construction material of the future".
86. (2013-01-25). "Cloned Cave Baby Lost in Translation".
87. Gary J. Remal. (January 22, 2013). "Harvard professor blasts Neanderthal clone baby rumor on Web". Boston Herald.
88. (January 23, 2013). "Spiegel responds to brouhaha over neanderthal clone".
89. Kluger, Jeffrey. (April 7, 2025). "The Return of the Dire Wolf".
90. Dickinson, Boonsri. (June 10, 2010). "Geneticist George Church: Sequencing human genome 'high priority' for China". Smart Planet.
91. Julia Karow. (July 6, 2010). "Pathogenica Bets on Next-Gen Sequencing for Fast, Multiplexed Pathogen Detection". GenomeWeb.
92. Luke Timmerman. (January 11, 2016). "Juno Acquires Harvard Spinout, AbVitro, For $125M To Discover More Cancer Immunotherapies".
93. Duncan, David. (June 7, 2010). "Scientist at Work: George M. Church – On a Mission to Sequence the Genomes of 100,000 People". The New York Times.
94. (March 12, 2007). "Biofuel startup raises $5 million". [[San Francisco Business Times]].
95. "Tech Transfer, Advisory Roles, and Funding Sources".
96. "10x Genomics Signs Agreement to Acquire ReadCoor".
97. "Open, Affordable Sequencing".
98. "Personal Genome Project".
99. (July 8, 2010). "Presidential Commission for the Study of Bioethical Issues".
100. "A Synthetic Biohazard Non-proliferation Proposal".
101. Church G. (November 24, 2005). "Let us go forth and safely multiply". Nature.
102. (2019-12-08). "Scientist George Church talks about accepting donations from Jeffrey Epstein".
103. "Personal Genetics Education Project".
104. (November 11, 2010). "Jemicy School for Dyslexia, David Malin Lecture".
105. Angrist M. (November 2009). "Eyes wide open: the Personal Genome Project, citizen science and veracity in informed consent". Personalized Medicine.
106. "Genomes, Environments and Traits (GET) Conference".
107. "Some scientists are taking a DIY coronavirus vaccine, and nobody knows if it's legal or if it works".
108. Church George. (2012). "Regenesis". Basic Books.
109. "The top 10 science books of 2012".
110. TEDx, 2012, "TEDxCambridge: George Church on genomics and human diversity", March 21, 2012, see [https://tedxtalks.ted.com/video/TEDxCambridge-George-Church-on;search%3AGeorge%20Church]. Retrieved March 4, 2014.
111. TEDx, 2013, "Hybridizing with extinct species: George Church at TEDxDeExtinction", May 8, 2013, see [https://tedxtalks.ted.com/video/Hybridizing-with-extinct-specie;search%3AGeorge%20Church]. Retrieved March 4, 2014.
112. TEDx, 2013, "DNA [as detectors], George-Church-at-TEDxCERN", May 24, 2013, see [https://tedxtalks.ted.com/video/DNA-George-Church-at-TEDxCERN]. Retrieved March 4, 2014.
113. "Charlie Rose - History".
114. "Church Lab News".
115. (May 18, 2016). "When George Church met Stephen Colbert".
116. "Church Writings, Master Class and Videos on Edge.org".
117. "About Our Mission, Team, and Editorial Ethics". Xconomy.
118. (27 May 2015). "The Church of George Church".
119. (2012). "National Academy of Engineering Elects 66 Members and 10 Foreign Associates". National Academies.
120. (2011). "Bower Award and Prize for Achievement in Science". Franklin Institute.
121. (June 8, 2009). "American Society for Microbiology honors George M. Church".
122. (2010). "International Steven Hoogendijk Award".
123. (December 19, 2008). "The Power of Ideas".
124. (September 8, 2010). "All-Star Awards". Mass High Tech.
125. (March 7, 2013). "SRF's Research Advisory Board Welcomes Dr. George Church".
126. (February 7, 2013). "Do inventors get enough respect in science?". [[The Boston Globe]].
127. "George Church".
128. (February 12, 2019). "A Bill of Rights for the Age of Artificial Intelligence". OneZero.
129. Herper, Matthew. (April 27, 2009). "Going To Church".
130. Thomas Goetz. (July 8, 2008). "How the Personal Genome Project Could Unlock the Mysteries of Life".
131. French, Kristen. (2023-01-25). "The Creative Sweet Spot of Dreaming".
132. Harmon, Amy. (November 13, 2017). "The Secret to Long Life? It May Lurk in the DNA of the Oldest Among Us". The New York Times.
133. (29 June 2023). "The Enhanced Olympics: Drugs welcome!". [[Reason (magazine).
134. (9 July 2023). "Games on steroids? Inside an Indian-origin man's plan to organise Enhanced Games". [[The Indian Express]].